MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder - Multiple Sclerosis and Related Disorders
Deciphering anti-MOG IgG antibodies: Clinical and radiological spectrum, and comparison of antibody detection assays - Journal of the Neurological Sciences
Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event | NEJM
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology
MOG Antibody / Anti MOG Support And Info | Facebook
IJMS | Free Full-Text | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management | HTML
New clinical implications of anti-myelin oligodendrocyte glycoprotein antibodies in children with CNS demyelinating diseases - Multiple Sclerosis and Related Disorders
MOG antibody-associated diseases | Neurology Neuroimmunology & Neuroinflammation
Anti-MOG Antibody Test Identifies Atypical Features, Prognosis in MS - Neurology Advisor
Anti-MOG encephalitis mimicking small vessel CNS vasculitis | Neurology Neuroimmunology & Neuroinflammation
Frontiers | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?
Spectrum of MOG antibody-associated disorders. | Download Scientific Diagram
Clinical and Experimental Pediatrics
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? | Neurology Neuroimmunology & Neuroinflammation
Table 1 from Defining distinct features of anti-MOG antibody associated central nervous system demyelination | Semantic Scholar
Figure 1 from Defining distinct features of anti-MOG antibody associated central nervous system demyelination | Semantic Scholar
Overview of patient cohort, antibody status, and anti-MOG antibody... | Download Scientific Diagram
Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination - ScienceDirect
Frontiers | MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder
JCI Insight - Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury
The spectrum of MOG autoantibody-associated demyelinating diseases | Nature Reviews Neurology
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype | Journal of Neuroinflammation | Full Text
Overview of patient cohort, antibody status, and anti-MOG antibody... | Download Scientific Diagram
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated CNS Demyelination: Clinical Spectrum and Comparison with Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Ojha PT, Aglave VB, Soni G, Jagiasi KA, Singh RK, Singh RK, Nagendra
Myelin oligodendrocyte glycoprotein antibodies in neurological disease | Nature Reviews Neurology
Myelin-oligodendrocyte glycoprotein antibody-associated disease - The Lancet Neurology
